2. Русак Ю.Э., Горшкова А.В., Ефанова Е.Н. Повышение эффективности терапии хронических дерматозов. РМЖ. 2021; 29(4): 78–80. [Rusak Yu.E., Gorshkova A.V., Efanova E.N. Improving the treatment efficacy of chronic dermatoses. Russkiy meditsinskiy zhurnal = Russian Medical Journal. 2021; 29(4): 78–80 (In Russ.)]. EDN: ZTIODP.

3. Brazao C., Pimenta R., Queiros C. et al. Cutaneous markers of cardiovascular diseases. Acta Med Port. 2022; 35(12): 899–907. https://dx.doi.org/10.20344/amp.18108.

4. Газданова А.А., Перков А.В., Лобанова К.К. с соавт. Дерматологические проявления ревматических заболеваний. Клиническая дерматология и венерология. 2022; 21(4): 548–554. [Gazdanova A.A., Perkov A.V., Lobanova K.K. et al. Dermatological manifestations of rheumatic diseases. Klinicheskaya dermatologiya i venerologiya = Russian Journal of Clinical Dermatology and Venereology. 2022; 21(4): 548–554 (In Russ.)]. https://dx.doi.org/10.17116/klinderma202221041548. EDN: VRZFOY.

5. Газданова А.А., Городецкая Г.И., Перков А.В. с соавт. Кожные проявления эндокринных заболеваний. Клиническая дерматология и венерология. 2022; 21(2): 230–237. [Gazdanova A.A., Gorodetskaya G.I., Perkov A.V. et al. Cutaneous manifestations of endocrine disorders. Klinicheskaya dermatologiya i venerologiya = Russian Journal of Clinical Dermatology and Venereology. 2022; 21(2): 230–237 (In Russ.)]. https://dx.doi.org/10.17116/klinderma202221021230. EDN: EAFAAU.

6. Иванов О.Л., Новоселов А.В., Новоселов В.С. Кожный синдром в практике гастроэнтеролога поликлиники. Терапевтический архив. 2009; 81(1): 25–29. [Ivanov O.L., Novoselov A.V., Novoselov V.S. Cutaneous syndrome in practice of the gastroenterologist of the outpatient clinic. Terapevticheskiy arkhiv = Therapeutic Archive. 2009; 81(1): 25–29 (In Russ.)]. EDN: HEIBDB.

7. Antonelli E., Bassotti G., Tramontana M. et al. Dermatological manifestations in inflammatory bowel diseases. J Clin Med. 2021; 10(2): 364. https://dx.doi.org/10.3390/jcm10020364.

8. Lalosevic M.S., Lalosevic J., Stjepanovic M. et al. Drug induced cutaneous manifestations due to treatment of gastrointestinal disorders. Curr Drug Metab. 2021; 22(2): 99–107. https://dx.doi.org/10.2174/1389200221999201116143109.

9. Lekwuttikarn R., Teng J.M.C. Cutaneous manifestations of nutritional deficiency. Curr Opin Pediatr. 2018; 30(4): 505–13. https://dx.doi.org/10.1097/MOP.0000000000000652.

10. Yi J.Z., Chen S.X., Lukac D., McGee J.S. Systemic comorbidities of rosacea: practice gaps among dermatologists. Arch Dermatol Res. 2022; 314(10): 995–97. https://dx.doi.org/10.1007/s00403-021-02279-y.

11. Матушевская Е.В., Комиссаренко И.А. Кожные проявления заболеваний желудочно-кишечного тракта. Экспериментальная и клиническая гастроэнтерология. 2019; (6): 86–92. [Matushevskaya E.V., Komissarenko I.A. Cutaneous manifestations of diseases of the gastrointestinal tract. Eksperimental’naya i klinicheskaya gastroenterologiya = Experimental and Clinical Gastroenterology. 2019; (6): 86–92 (In Russ.)]. https://dx.doi.org/10.31146/1682-8658-ecg-166-6-86-92. EDN: HWKDRH.

12. Максимова Е.В., Кляритская И.Л., Григоренко Е.И. с соавт. Дерматологические проявления инфекции Helicobacter pylori. Крымский терапевтический журнал. 2019; (4): 47–52. [Maksimova E.V., Kliaritskaia I.L., Grigorenko E.I. et al. Dermatological manifestations of Helicobacter pylori infection. Krymskiy terapevticheskiy zhurnal = Crimean Therapeutic Journal. 2019; (4): 47–52 (In Russ.)]. EDN: FFPMOW.

13. Zheleznov S., Urzhumtseva G., Petrova N. et al. Gastritis can cause and trigger chronic spontaneous urticaria independent of the presence of Helicobacter pylori. Int Arch Allergy Immunol. 2018; 175(4): 246–51. https://dx.doi.org/10.1159/000487669.

14. Curth H.M., Dinter J., Nigemeier K. et al. Effects of Helicobacter pylori eradication in chronic spontaneous urticaria: Results from a retrospective cohort study. Am J Clin Dermatol. 2015; 16(6): 553–58. https://dx.doi.org/10.1007/s40257-015-0152-6.

15. Wang F.Y., Chi C.C. Rosacea, germs, and bowels: A review on gastrointestinal comorbidities and gut-skin axis of rosacea. Adv Ther. 2021; 38(3): 1415–24. https://dx.doi.org/10.1007/s12325-021-01624-x.

16. Searle T., Ali F.R., Carolides S., Al-Niaimi F. Rosacea and the gastrointestinal system. Australas J Dermatol. 2020; 61(4): 307–11. https://dx.doi.org/10.1111/ajd.13401.

17. Le S.T., Toussi A., Maverakis N. et al. The cutaneous and intestinal microbiome in psoriatic disease. Clin Immunol. 2020; 218: 108537. https://dx.doi.org/10.1016/j.clim.2020.108537.

18. Molnar J., Mallonee C.J., Stanisic D. et al. Hidradenitis suppurativa and 1-carbon metabolism: Role of gut microbiome, matrix metalloproteinases, and hyperhomocysteinemia. Front Immunol. 2020; 11: 1730. https://dx.doi.org/10.3389/fimmu.2020.01730.

19. Атопический дерматит в схемах и таблицах. Педиатрия. Приложение к журналу Consilium Medicum. 2017; (1): 98–102. [Atopic dermatitis in charts and tables. Pediatriya. Prilozheniye k zhurnalu Consilium Medicum = Pediatrics. Supplement to Consilium Medicum. 2017; (1): 98–102 (In Russ.)]. EDN: YPSTML.

20. Li W., Yosipovitch G. The role of the microbiome and microbiome-derived metabolites in atopic dermatitis and non-histaminergic itch. Am J Clin Dermatol. 2020; 21(1): 44–50. https://dx.doi.org/10.1007/s40257-020-00538-8.

21. Walter A., Seegraber M., Wollenberg A. Food-related contact dermatitis, contact urticaria, and atopy patch test with food. Clin Rev Allergy Immunol. 2019; 56(1): 19–31. https://dx.doi.org/10.1007/s12016-018-8687-y.

22. Lopez C.M., Yarrarapu S.N.S., Mendez M.D. Food allergies. 2021; In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. PMID: 29489188.

23. [Suh H.Y., Lee W.J., Na S.Y. [Dermatologic manifestations in inflammatory bowel disease. Korean J Gastroenterol. 2019; 73(5): 285–93 (In Korean)]. https://dx.doi.org/10.4166/kjg.2019.73.5.285

24. Jansen F.M., Vavricka S.R., den Broeder A.A. et al. Clinical management of the most common extra-intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes. United European Gastroenterol J. 2020; 8(9): 1031–44. https://dx.doi.org/10.1177/2050640620958902.

25. Sun Y., Li Y., Zhang J. The causal relationship between psoriasis, psoriatic arthritis, and inflammatory bowel diseases. Sci Rep. 2022; 12(1): 20526. https://dx.doi.org/10.1038/s41598-022-24872-5.

26. Bao B., Zhu C., Shi J., Lu C. Causal association between inflammatory bowel disease and hidradenitis suppurativa: A two-sample bidirectional Mendelian randomization study. Front Immunol. 2023; 14: 1071616. https://dx.doi.org/10.3389/fimmu.2023.1071616.

27. Huda S.A., Kahlown S., Jilani M.H. et al. The Sweet syndrome as a cutaneous manifestation of Crohn’s disease. Proc (Bayl Univ Med Cent). 2020; 33(3): 395–97. https://dx.doi.org/10.1080/08998280.2020.1753457.

28. [Bres A., Galvez P., Fricain J.C. Cutaneous manifestation enabling early diagnosis of Crohn’s disease. Ann Dermatol Venereol. 2020; 147(12): 912–13 (In French)]. https://dx.doi.org/10.1016/j.annder.2020.06.019.

29. Diaconescu S., Strat S., Balan G.G. et al. Dermatological manifestations in pediatric inflammatory bowel disease. Medicina (Kaunas). 2020; 56(9): 425. https://dx.doi.org/10.3390/medicina56090425.

30. Chatzinasiou F., Polymeros D., Panagiotou M. et al. Generalized pyoderma gangrenosum associated with ulcerative colitis: Successful treatment with infliximab and azathioprine. Acta Dermatovenerol Croat. 2016; 24(1): 83–85.

31. Lee H., Song W.J., Koh S.J., Park H. Epidemiological association between alopecia areata and celiac disease: A meta-analysis. J Dermatol. 2022; 49(11): e399–400. https://dx.doi.org/10.1111/1346-8138.16478.

32. Rodrigo L., Beteta-Gorriti V., Alvarez N. et al. Cutaneous and mucosal manifestations associated with celiac disease. Nutrients. 2018; 10(7): 800. https://dx.doi.org/10.3390/nu10070800.

33. Lebwohl B., Soderling J., Roelstraete B. et al. Risk of skin disorders in patients with celiac disease: A population-based cohort study. J Am Acad Dermatol. 2021; 85(6): 1456–64. https://dx.doi.org/10.1016/j.jaad.2020.10.079.

34. Persechino F., Galli G., Persechino S. et al. Skin manifestations and coeliac disease in paediatric population. Nutrients. 2021; 13(10): 3611. https://dx.doi.org/10.3390/nu13103611.

35. Antunes C., Singhal M. Whipple disease. 2021. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2021. PMID: 28722966.

36. Munjal Y., Munjal S.D., Tiwari R. Whipple’s disease: Rare case of malabsorption with hyperpigmentation in a female. Indian J Pathol Microbiol. 2021; 64(4): 788–90. https://dx.doi.org/10.4103/IJPM.IJPM_887_20.

37. Borretta L., Walsh N.M., Bakowsky V. et al. A case of Whipple disease with cutaneous manifestations. Am J Dermatopathol. 2021; 43(9): e10 –6. https://dx.doi.org/10.1097/DAD.0000000000001925.

38. Solis-Garcia Del Pozo J., de Cabo C., Solera J. Gastrointestinal manifestations in Satoyoshi syndrome: A systematic review. Orphanet J Rare Dis. 2020; 15(1): 115. https://dx.doi.org/10.1186/s13023-020-01395-8.

39. Rudnicka L., Kwiatkowska M., Rakowska A. et al. Alopecia areata. How not to miss Satoyoshi syndrome? J Dermatol. 2014; 41(11): 951–56. https://dx.doi.org/10.1111/1346-8138.12633.

40. 4Sanghvi S.Y., Schwartz R.A. Leiner’s disease (erythroderma desquamativum): A review and approach to therapy. Dermatol Ther. 2021; 34(1): e14510. https://dx.doi.org/10.1111/dth.14510.

41. Halabi I., Barohom M.N., Peleg S. et al. Case report: Severe hypocalcemic episodes due to autoimmune enteropathy. Front Endocrinol (Lausanne). 2021; 12 :645279. https://dx.doi.org/10.3389/fendo.2021.645279.

42. Silverio Ade O., Guimaraes D.C., Elias L.F. et al. Are the spider angiomas skin markers of hepatopulmonary syndrome? Arq Gastroenterol. 2013; 50(3): 175–79. https://dx.doi.org/10.1590/S0004-28032013000200031.

43. Liu Y., Zhao Y., Gao X. et al. Recognizing skin conditions in patients with cirrhosis: A narrative review. Ann Med. 2022; 54(1): 3017–29. https://dx.doi.org/10.1080/07853890.2022.2138961.

44. Dogra S., Jindal R. Cutaneous manifestations of common liver diseases. J Clin Exp Hepatol. 2011; 1(3): 177–84. https://dx.doi.org/10.1016/S0973-6883(11)60235-1.

45. Patel A.D., Katz K., Gordon K.B. Cutaneous manifestations of chronic liver disease. Clin Liver Dis. 2020; 24(3): 351–60. https://dx.doi.org/10.1016/j.cld.2020.04.003.

46. Fernandez-Somoza J.M., Ginarte M., Otero E. et al. Clinical and capillaroscopic findings in patients with liver disease and proximal apparent leukonychia (Terry nails and its variants). Medicine (Baltimore). 2021; 100(22): e26207. https://dx.doi.org/10.1097/MD.0000000000026207.

47. Wang C.R., Tsai H.W. Human hepatitis viruses-associated cutaneous and systemic vasculitis. World J Gastroenterol. 2021; 27(1): 19–36. https://dx.doi.org/10.3748/wjg.v27.i1.19.

48. [Alvarez Aguilar P.A., Angulo Mora S. Xanthomas and xanthelasmas in primary biliary cholangitis. Med Clin (Barc). 2019; 153(1): 46 (In English, Spanish)]. https://dx.doi.org/10.1016/j.medcli.2018.10.003.

49. Bhandari A., Mahajan R. Skin changes in cirrhosis. J Clin Exp Hepatol. 2022; 12(4): 1215–24. https://dx.doi.org/10.1016/j.jceh.2021.12.013.

50. Miulescu R., Balaban D.V., Sandru F., Jinga M. Cutaneous manifestations in pancreatic diseases – A review. J Clin Med. 2020; 9(8): 2611. https://dx.doi.org/10.3390/jcm9082611.

51. Szabo C.E., Man O.I., Serban R.S. et al. Bruising as the first sign of exocrine pancreatic insufficiency in infancy. Med Pharm Rep. 2019; 92(2): 200–4. https://dx.doi.org/10.15386/mpr-1231.

52. Еремина Т.А., Позднякова О.Н. Хронические дерматозы, ассоциированные с синдромом мальабсорбции. Медицина и образование в Сибири. 2012; (1): 22. [Eremina T.A., Pozdnyakova O.N. Chronic dermatosis associated with malabsorbtion syndrom. Meditsina i obrazovaniye v Sibiri = Medicine and Education in Siberia. 2012; (1): 22 (In Russ.)]. EDN: PBZZHV.

53. Gueant J.L., Gueant-Rodriguez R.M., Alpers D.H. Vitamin B12 absorption and malabsorption. Vitam Horm. 2022; 119: 241–74. https://dx.doi.org/10.1016/bs.vh.2022.01.016.

54. Normatov I., Sentongo T. Pancreatic malnutrition in children. Pediatr Ann. 2019; 48(11): e441–47. https://dx.doi.org/10.3928/19382359-20191018-01

55. Nosewicz J., Sparks A., Hart P.A. et al. The evaluation and management of macronutrient deficiency dermatoses. J Am Acad Dermatol. 2022; 87(3): 640–47. https://dx.doi.org/10.1016/j.jaad.2022.04.007.

56. Ikuse T., Kudo T., Arai K. et al. Shwachman–Diamond syndrome: Nationwide survey and systematic review in Japan. Pediatr Int. 2018; 60(8): 719–26. https://dx.doi.org/10.1111/ped.13601.

57. Сереброва С.Ю. Гастроэнтерологические аспекты муковисцидоза. РМЖ. 2008; (1): 1. [Serebrova S.Yu. Gastroenterological aspects of cystic fibrosis. Russkiy meditsinskiy zhurnal = Russian Medical Journal. 2008; (1): 1 (In Russ.)].

58. [Morfin-Maciel B.M., Garcia-de la Puente S., Huante-Anaya A., Bojorquez-Ochoa A. The prevalence of allergic diseases in children with short bowel syndrome. Rev Alerg Mex. 2020; 67(4): 329–37 (In Spanish)]. https://dx.doi.org/10.29262/ram.v67i4.801

59. Pironi L., Corcos O., Forbes A. et al.; ESPEN Acute and Chronic Intestinal Failure Special Interest Groups. Intestinal failure in adults: Recommendations from the ESPEN expert groups. Clin Nutr. 2018; 37(6 Pt A): 1798–809. https://dx.doi.org/10.1016/j.clnu.2018.07.036

60. Zhu C., Li Y. An updated overview of glucagon-like peptide-2 analog trophic therapy for short bowel syndrome in adults. J Int Med Res. 2022; 50(3): 3000605221086145. https://dx.doi.org/10.1177/03000605221086145

61. Garcovich S., De Simone C., Giovanardi G. et al. Post-bariatric surgery hidradenitis suppurativa: A new patient subset associated with malabsorption and micronutritional deficiencies. Clin Exp Dermatol. 2019; 44(3): 283–89. https://dx.doi.org/10.1111/ced.13732.

62. Lemieux L.M., Surampudi V. Severe vitamin A deficiency after biliopancreatic diversion. J Investig Med High Impact Case Rep. 2019; 7: 2324709619888051. https://dx.doi.org/10.1177/2324709619888051.